Percheron Therapeutics Limited logo

Percheron Therapeutics Limited (PER)

Market Closed
ASX ASX
- Market Cap
- P/E Ratio
- Div Yield
5.97M Volume
- Eps
Want to track PER and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
17 Feb 2026
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
27 Aug 2025
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
26 Feb 2025
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
14 Nov 2024
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
26 Jul 2024
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
30 Apr 2024
-
-
Percheron Therapeutics Limited logo
PER Percheron Therapeutics Limited
20 Feb 2024
-
-

PER Earnings Reports FAQ

What is the earnings per share (EPS) for PER?

EPS data for PER is currently not available, as Percheron Therapeutics Limited has not reported recent earnings.

What is the company's earnings growth rate?

Percheron Therapeutics Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Percheron Therapeutics Limited has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Percheron Therapeutics Limited are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for PER at this time, as Percheron Therapeutics Limited has no recent EPS data to calculate it.